Stephen Brady
Chief Executive Officer bij TEMPEST THERAPEUTICS, INC.
Vermogen: 11 130 $ op 29-02-2024
Profiel
Presently, Stephen R.
Brady holds the position of President, Chief Executive Officer & Director at Tempest Therapeutics, Inc. He is also on the board of Biotechnology Innovation Organization and Atreca, Inc.
He previously was Chief Business Officer of Sagimet Biosciences, Inc., Associate for Morrison & Foerster LLP, Senior Corporate Counsel at Lexicon Pharmaceuticals, Inc., President & Chief Operating Officer at TempestTx, Inc., Vice President-Venture Advisors at Lazard Frères & Co. LLC, Vice President-Corporate Development for Proteolix, Inc. and Executive Vice President-Strategy & Finance at Immune Design Corp.
He received an undergraduate degree from the University of Oregon, a graduate degree from New York University School of Law and a graduate degree from the University of the Pacific.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
03-01-2024 | 3 000 ( 0.02% ) | 11 130 $ | 29-02-2024 | |
ATRECA, INC. CLASS A
-.--% | 13-06-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Stephen Brady
Bedrijven | Functie | Begin |
---|---|---|
TEMPEST THERAPEUTICS, INC. | Chief Executive Officer | 01-06-2021 |
ATRECA, INC. | Director/Board Member | 14-07-2021 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 01-01-2022 |
Eerdere bekende functies van Stephen Brady
Bedrijven | Functie | Einde |
---|---|---|
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | President | 01-06-2021 |
IMMUNE DESIGN CORP | Corporate Officer/Principal | 02-04-2019 |
SAGIMET BIOSCIENCES INC. | Chief Operating Officer | 11-02-2011 |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | General Counsel | 25-03-2009 |
LEXICON PHARMACEUTICALS, INC. | General Counsel | 01-01-2007 |
Opleiding van Stephen Brady
University of Oregon | Undergraduate Degree |
University of the Pacific | Graduate Degree |
New York University School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
LEXICON PHARMACEUTICALS, INC. | Health Technology |
ATRECA, INC. | Health Technology |
SAGIMET BIOSCIENCES INC. | Health Technology |
TEMPEST THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Lazard Frères & Co. LLC
Lazard Frères & Co. LLC Investment ManagersFinance Lazard Freres & Co. LLC provides corporate advisory, capital market, and asset management services. The company was founded on April 13, 1992 and is headquartered in New York, NY. | Finance |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | Health Technology |
Morrison & Foerster LLP
Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Morrison & Foerster LLP is a law firm that provides legal services on various industries, which include: litigation, financial services, intellectual property and technology, and transactional work, such as corporate, capital markets and real estate finance representations. The company was founded in 1883 and is headquartered in San Francisco, CA. | Commercial Services |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Health Technology |
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |